Partnerships

SimuGen's intuitive, accurate and high-throughput genomics products and services can be easily integrated into your current early stage ADMET and drug discovery workflow and will contribute significantly to your decision making processes.

SimuGen's flagship predictive liver toxicology product allows you to assess the risk of your drug programmes over a wide spectrum of safety concerns. The company is already working with a number of global partner companies and continues to look for further development and marketing partnerships.

SimuGen's vision is to continue expanding partnerships along three paths:

• Application to different cell culture models for multiple target organ toxicities
• Addressing drug withdrawals from the market due to safety problems
• Providing the current pharma-focused tools to other industries requiring early-stage safety screening

" SimuGen is your partner of choice for intuitive and reliable risk assessment of your drug programmes"